Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Slippery elm bark, derived from the inner bark of the *Ulmus rubra* tree, is a traditional herbal remedy primarily used for its demulcent properties. It contains a high concentration of mucilage, which, when mixed with water, forms a gel-like substance that can coat and soothe irritated mucous membranes in the gastrointestinal tract. It is frequently investigated for its potential benefits in treating inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and intestinal barrier dysfunction (leaky gut). Clinical studies have explored its use both as a standalone ingredient and as part of multi-herb formulations to improve stool consistency and reduce symptoms like bloating and abdominal pain. Historically, it was also used in the manufacture of bougies for medical procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on slippery elm bark.